Genecin, Yale Health CEO, to retire in January 2023

Dr. Paul Genecin, chief executive officer of Yale Health, will retire early next year after 33 years of service to the university, President Salovey announced.
Paul Genecin

Paul Genecin

Dr. Paul Genecin, chief executive officer of Yale Health, will retire early next year after 33 years of service to the university, Yale President Peter Salovey announced Aug. 10.

A champion of high-quality, data-driven, patient-centered care, Dr. Genecin has contributed immeasurably to the health and well-being of generations of Yale community members,” the president wrote in a message to the university community, which also underscored Genecin’s key role in Yale’s response to the COVID-19 pandemic.

Salovey will soon form an advisory committee to guide the search for a new Yale Health CEO. He has asked Dr. Stephanie Spangler, vice provost for health affairs and academic integrity, and John Whelan, vice president for human resources, to advise him in the search process.

Yale Health is the staff model health maintenance organization (HMO) that provides comprehensive care and coverage to Yale University students, faculty, staff, and their families.

Genecin, who formally retires Jan. 6, 2023, joined Yale Health in 1989 for a one-year appointment as a primary care internist. He stayed on for a second year, and subsequently was appointed chief of the Internal Medicine Department. In that role, he built a strong team of physicians and implemented strategies to improve the quality of patient care, such as increasing the number of highly skilled advanced practice providers and nurses, and expanding patient access. He was named CEO in 1997.

Faculty, staff, and students recognized his deep commitment to their health, and his colleagues appreciated his talent for managing medical teams and creating opportunities for enhancing clinical care, Salovey wrote.

While leading Yale Health, Genecin has focused on clinical quality and launched numerous initiatives to measure and improve patient care. The introduction of electronic medical records to Yale Health years before the wider medical community migrated to Epic — a medical record system now used by health care organizations nationwide — was an early accomplishment. Using data from the electronic records, Genecin’s team applied rigorous metrics to ensure Yale Health provides high quality and evidence-based care.

These data-driven approaches have involved identifying quality improvement opportunities in routine services and age-appropriate health screening to optimize care for those with high-risk conditions such as diabetes and other chronic diseases. In addition, Genecin has used health data, operational metrics, and patient feedback to ensure that Yale Health’s services have grown and expanded to meet the community’s needs. He also forged a clinical partnership with Yale Medicine to provide patients comprehensive specialty services, increasing connectivity between Yale Medicine specialists and Yale Health primary care clinicians.

I have had the great privilege to know and work with Paul Genecin since he arrived at Yale Health over 30 years ago — and to admire and support his rise in the leadership ranks,” Spangler said. “Throughout his tenure he has been unflagging in his deep commitment to high-quality care for each patient and the health of the Yale community as a whole.”

When Yale Health outgrew its former facilities at 17 Hillhouse Ave., Genecin worked with other university leaders and colleagues across campus to define the needs of a modern health care facility, culminating in the 2010 opening of the Yale Health Center at 55 Lock Street. It greatly expanded clinic space and enhanced services, including radiology and gastrointestinal endoscopy, among many others.

In 2005, the Joint Commission — a health care accreditation organization dedicated to continuous quality improvement — accredited Yale Health as an inpatient and ambulatory clinic. In 2012, the National Committee for Quality Assurance certified Yale Health as a patient-centered medical home, and soon after the Joint Commission recognized Yale Health as a primary care medical home.

These milestones demonstrate how Dr. Genecin and the Yale Health staff have stayed focused on optimizing care for our diverse university population over the years,” Salovey wrote. “They have worked steadily to take into account patients’ preferences, cultures, values, and beliefs in all medical interactions, striving to engage patients in shared decision-making and coordinating their care across all settings.”

During the pandemic, Yale Health mobilized quickly under Dr. Genecin’s leadership to be able to provide care to the Yale community. It successfully established infection control procedures and found innovative ways not only to care for COVID-19 patients but also to continue non-COVID services, maintaining the organization’s record of clinical excellence using quality metrics as patient care transitioned to telemedicine.

I came to know Paul via Yale’s COVID advisory committee in spring 2020. That experience revealed the complexity of university operations that most community members take for granted,” said Edward Kaplan, the William N. and Marie A. Beach Professor of Operations Research at the Yale School of Management. “Yale Health was responsible for the health care of students, staff and faculty, and we are all fortunate that Paul Genecin was there to lead with skill and compassion.”

Even before the pandemic, college campuses nationwide were experiencing increasing demand for mental health care services. In response, Genecin assembled a team of psychiatrists, psychologists, and clinical social workers to meet the needs of Yale students. Most recently, he collaborated with colleagues at Yale Health, Yale College, the Graduate School of Arts and Sciences, and the professional schools to increase access to services within each school. These efforts include the launch of the Yale College Community Care (YC3) pilot, which added eight full-time staff members working within the residential colleges to help students with emotional concerns.

A committed physician and innovative leader,” Salovey wrote, “Dr. Genecin leaves his position after ensuring Yale Health is operating at the fore of patient-centered clinical care.”

Share this with Facebook Share this with X Share this with LinkedIn Share this with Email Print this

Media Contact

Karen N. Peart:, 203-980-2222